Indigotindisulfonate sodium 0.8%

DRUG2 trials

Sponsors

Prove pharm

Conditions

Ureter Injury

Phase 4

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency

RecruitingNCT06054880

Prove pharmUreter Injury

Start: 2023-10-12End: 2026-02-28Target: 116Updated: 2026-01-22

Indigotindisulfonate Sodium as an Aid in Determination of Ureteral Patency in Patient's With Renal Impairment

RecruitingNCT06085183

Prove pharmUreter Injury

Start: 2023-12-20End: 2026-07-31Target: 48Updated: 2026-01-22